Continuous Glucose Monitoring: A Pilot Study
NCT: NCT06614127 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this study is to evaluate connectivity of the FDA approved DexCom G7® continuous glucose monitor in the operating room. Continuous glucose monitors are applied to the skin and a thin sampling filament is inserted into the skin and measures blood sugar in the interstitial fluid. The DexCom G7® is used regularly outside of the operating room to monitor blood sugar, however the use of the device in the operating room environment has been limited by connectivity issues. This study will assess device connectivity at different monitoring sites.
Frequently Asked Questions
What is Continuous Glucose Monitoring: A Pilot Study?
Continuous Glucose Monitoring: A Pilot Study is a clinical trial registered under NCT06614127. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06614127?
The current status of NCT06614127 (Continuous Glucose Monitoring: A Pilot Study) is: ACTIVE_NOT_RECRUITING.
When did Continuous Glucose Monitoring: A Pilot Study start?
Continuous Glucose Monitoring: A Pilot Study started on 2024-10-24.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.